Patanjali, run by Yoga guru Swami Ramdev, has just launched ‘Coronil’ and ‘Swasari’ tablets, which it claims to be an Ayurvedic cure for COVID-19.
The company is said to have conducted clinical control trials of this medicine. Based on the results, the MD of Patanjali Ayurved, Acharya Balakrishna claimed all those patients, who were affected by coronavirus and underwent clinical trials, tested negative within a span of 3-15 days without any mortalities. However, the company has not yet revealed the clinical study details, while sources also reported that the drug has not yet been approved. Further, the Health Ministry or the ICMR (Indian Council of Medical Research) or the Ayush Ministry have not stated anything on these claims.
These medicines have been launched following a long research that was conducted by Patanjali Research Institute in association with National Institute of Medical Science. They got a team of scientists working on it right from December 2019 when the outbreak had just begun.
At a press meet in Haridwar, Ramdev said – “We are launching Covid medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this, 280 patients were included and 100 per cent of those recovered. We were able to control coronavirus and its complications in this. After this the all-important clinical control trial was conducted.”
Patanjali’s Corona Kit will be available at INR 545, though it’s not available anywhere at the moment. Within a week, it will be available at all Patanjali stores. They are also planning to launch an app for the delivery of this kit.
Ramdev emphasized that the required approvals for conducting the clinical trials on COVID-19 patients were taken from the respective authorities.